Tumor markers in staging and prognosis of colorectal carcinoma

Neoplasma

Volumn 55, Issue 2, 2008, Pages 138-142

  Levy, M ^a   Visokai, V ^a   Lipska, L ^a   Topolcan, O ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Colorectal carcinoma; Prognosis; Staging; Tumor markers

Indexed keywords

ADIPONECTIN; CA 19-9 ANTIGEN; CA 242 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN; ONCOFETAL ANTIGEN; SOMATOMEDIN C; THYMIDINE KINASE; TUMOR MARKER; VASCULAR CELL ADHESION MOLECULE 1; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BIOLOGICAL ACTIVITY; CANCER STAGING; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; PROTEIN BLOOD LEVEL; BLOOD; COLORECTAL TUMOR; MORTALITY; PATHOLOGY;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 48549094108     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. DANIELS IR, FISHER SE, HEALD RJ, MORAN BJ., Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence, Colorectal Dis. 2007; 9(4): 290-301.
2. STEIN U, SCHLAG PM. Clinical, biological, and molecular aspects of metastasis in colorectal cancer. Recent Results Cancer Res. 2007; 176: 61-80.
3. KANEKO I, TANAKA S, OKA S, et al. Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer. World J Gastroenterol. 2007; 13(28): 3829-3835
4. OGINO S, KAWASAKI T, KIRKNER GJET al. Evaluation of Markers for CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer by a Large Population-Based Sample.J Mol Diagn. 2007; 9(3): 305-314.
5. FAMULSKI W, SULKOWSKA M, WINCEWICZ A et al. P53 correlates positively with VEGF in preoperative sera of colorectal cancor patients. Neoplasma. 2006; 53(1): 43-48
6. DUFFY MJ, van DALEN A, HAGLUND C et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007; 43(9): 1348-1360
7. VISOKAI V, LIPSKA L, BERGMANN P et al. Multiorgan resections for advanced colorectal cancer.Anticancer Res. 2006; 26(4B): 3183-3186
8. Wei EK, Giovannucci E, Fuchs CSet al. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.J Natl Cancer Inst. 2005; 97(22): 1688-1694
9. VELIKOVA G, BANKS RE, GEARING A et al. .Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br J Cancer. 1998; 77: 1857-1863 (Pubitemid 28254624)
10. TANIGAWA N, MASUDA Y, MURAOKA R et al. Prognostic significance of in vitro thymidine uptake in patients with colorectal carcinoma.J Surg Oncol. 1994; 55(4): 209-214
11. THOMAS WM, ROBERTSON JF, McKENNA PG et al. Serum thymidine kinase in colorectal neoplasia.Eur J Surg Oncol. 1995; 21(6): 632-634
12. TOPOLCAN O, HOLUBEC L Jr, FINEK J et al. Changes of thymidine kinase (TK) during adjuvant and palliative chemotherapy. Anticancer Res. 2005; 25(3A): 1831-1833 (Pubitemid 40896812)
13. ESKELINEN M, PASANEN P, KULJU A et al.Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer. Anticancer Res. 1994; 14(3B): 1427-1432
14. KUUSELA P, HAGLUND C, ROBERTS PJ. Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer. 1991; 63(4): 636-640
15. KAWA S, TOKOO M, HASEBE O et al. Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer. Br J Cancer. 1994; 70(3): 481-486
16. SPILA A, FERRONI P, COSIMELLI M et al.. Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer. Anticancer Res. 1999; 19(2B): 1363-1368 (Pubitemid 29257460)
17. CARPELAN-HOLMSTROM M, HAGLUND C, LUNDIN J et al. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer. Br J Cancer. 1996; 74(6): 925-929